UFF
JAZZ icon

USA Financial Formulas’s Jazz Pharmaceuticals JAZZ Stock Holding History

USA Financial Formulas’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Buy
+132
New +$23.1K ﹤0.01% 242
2025
Q2 		– Sell
-2,710
Closed -$336K – 308
2025
Q1 		$336K Buy
+2,710
New +$354K 0.06% 100
2022
Q3 		$300K Buy
+2,254
New +$343K 0.47% 44

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

USA Financial Formulas's JAZZ Position: Q1 2026 in Review

USA Financial Formulas opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 132 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #242 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in JAZZ as recently as Q1 2025.

USA Financial Formulas first reported a position in JAZZ in Q3 2022 and has held it in 3 quarters since. The position peaked at $336K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • USA Financial Formulas held 132 shares of Jazz Pharmaceuticals worth $25K as of Q1 2026.
  • Jazz Pharmaceuticals was a new USA Financial Formulas position in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #242 holding.
  • USA Financial Formulas first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • USA Financial Formulas's Jazz Pharmaceuticals position peaked at $336K in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.